D
Cullinan Therapeutics, Inc. CGEM
$9.07 $0.111.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -48.50M -47.65M -40.56M -42.03M -37.15M
Total Depreciation and Amortization 76.00K 77.00K 76.00K 77.00K 76.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.06M 6.12M 4.50M 6.81M 4.73M
Change in Net Operating Assets -1.79M 4.82M 1.84M -1.15M -5.90M
Cash from Operations -43.16M -36.63M -34.14M -36.29M -38.25M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 36.81M 15.96M 19.88M -185.11M 12.96M
Cash from Investing 36.81M 15.96M 19.88M -185.11M 12.96M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 1.58M 1.98M 265.99M 1.09M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 0.00 -656.00K -3.79M --
Cash from Financing -- 1.58M 1.33M 262.20M 1.09M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -6.35M -19.08M -12.94M 40.79M -24.21M